Earnings estimate | Current qtr. (Dec 2022) | Next qtr. (Mar 2023) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
No. of analysts | 2 | 1 | 2 | 2 |
Avg. Estimate | -0.1 | -0.1 | 0.92 | -0.21 |
Low estimate | -0.13 | -0.1 | 0.9 | -0.36 |
High estimate | -0.08 | -0.1 | 0.94 | -0.06 |
Year ago EPS | -0.64 | -0.46 | -2.87 | 0.92 |
Revenue estimate | Current qtr. (Dec 2022) | Next qtr. (Mar 2023) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
No. of analysts | 2 | 1 | 2 | 2 |
Avg. Estimate | N/A | N/A | 800k | 500k |
Low estimate | N/A | N/A | 790k | N/A |
High estimate | N/A | N/A | 800k | 1M |
Year ago sales | 2.44M | 794k | 7.34M | 800k |
Sales growth (year/est) | N/A | N/A | -89.10% | -37.50% |
Earnings history | 30/12/2021 | 30/03/2022 | 29/06/2022 | 29/09/2022 |
---|---|---|---|---|
Est. EPS | -0.59 | -0.44 | -0.24 | -0.1 |
Actual EPS | -0.64 | -0.46 | 1.64 | -0.16 |
Difference | -0.05 | -0.02 | 1.88 | -0.06 |
Surprise % | -8.50% | -4.50% | 783.30% | -60.00% |
EPS trend | Current qtr. (Dec 2022) | Next qtr. (Mar 2023) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
Current estimate | -0.1 | -0.1 | 0.92 | -0.21 |
7 days ago | -0.1 | -0.1 | 0.92 | -0.21 |
30 days ago | -0.1 | -0.1 | 0.92 | -0.21 |
60 days ago | -0.13 | -0.1 | 0.9 | -0.36 |
90 days ago | -0.08 | -0.08 | 1 | -0.32 |
EPS revisions | Current qtr. (Dec 2022) | Next qtr. (Mar 2023) | Current year (2022) | Next year (2023) |
---|---|---|---|---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | CBIO | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | 84.40% | N/A | N/A | N/A |
Next qtr. | 78.30% | N/A | N/A | N/A |
Current year | 132.10% | N/A | N/A | N/A |
Next year | -122.80% | N/A | N/A | N/A |
Next 5 years (per annum) | -23.33% | N/A | N/A | N/A |
Past 5 years (per annum) | N/A | N/A | N/A | N/A |